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Abstract
Epigenetic mechanisms have emerged as links between prenatal
environmental exposure and disease risk later in life. Here, we
studied epigenetic changes associated with maternal smoking at
base pair resolution by mapping DNA methylation, histone modifi-
cations, and transcription in expectant mothers and their newborn
children. We found extensive global differential methylation and
carefully evaluated these changes to separate environment associ-
ated from genotype-related DNA methylation changes. Differential
methylation is enriched in enhancer elements and targets in
particular “commuting” enhancers having multiple, regulatory
interactions with distal genes. Longitudinal whole-genome bisul-
fite sequencing revealed that DNA methylation changes associated
with maternal smoking persist over years of life. Particularly in
children prenatal environmental exposure leads to chromatin tran-
sitions into a hyperactive state. Combined DNA methylation,
histone modification, and gene expression analyses indicate that
differential methylation in enhancer regions is more often func-
tionally translated than methylation changes in promoters or
non-regulatory elements. Finally, we show that epigenetic deregu-
lation of a commuting enhancer targeting c-Jun N-terminal kinase
2 (JNK2) is linked to impaired lung function in early childhood.
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Introduction
Altered epigenetic patterns represent an attractive explanation for
understanding the phenotypic changes associated with environmen-
tal exposure. By affecting DNA methylation, post-translational
histone modification, or non-coding RNA (ncRNA) signaling, envi-
ronmental factors may cause persistent perturbations of regulatory
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pathways and thus induce an altered susceptibility for disease
(Aguilera et al, 2010). Many lines of evidence indicate that early life
and in particular the prenatal period represent a window of high
vulnerability to environmental impacts with consequences for
disease risk later in children’s life. The subsequent manifestation of
a disease may occur with long latency periods as shown in the
Dutch Hunger Winter study. This study revealed that starvation
during pregnancy increased the risk for several diseases later in chil-
dren’s life including type II diabetes, cardiovascular diseases, or
decreased cognitive function (Brown et al, 1995; Susser et al, 1996;
Roseboom et al, 2001; Painter et al, 2005; Veenendaal et al, 2013).
Experimental models suggest that the in utero nutritional environ-
ment resulting from starvation induces epigenetic modifications
including altered DNA methylation (Radford et al, 2014) and the
generation of small RNAs (Rechavi et al, 2014) that are inherited in
the next generation.
One of the most common hazardous prenatal exposures is mater-
nal smoking. Prenatal exposure to tobacco smoke was described as
a risk factor for a multitude of different diseases in the child, includ-
ing lung diseases, obesity, and cancer (Hemminki & Chen, 2006;
Oken et al, 2008; Neuman et al, 2012). Several studies have focused
on DNA methylation in cord blood to elucidate the influence of
smoking and other prenatal exposures on the newborn’s epigenome
by analyzing global DNA methylation changes (i.e., in repetitive
elements) or methylation of a limited number of preselected CpG
probes (i.e., 27k methylation or 450k arrays) (Breton et al, 2009;
Joubert et al, 2012; Murphy et al, 2012; Markunas et al, 2014;
Kupers et al, 2015; Richmond et al, 2015). From these earlier
epidemiological studies, information on global and site-specific
methylation changes is available, but the insights derived from
those studies remain very limited. Importantly, these earlier investi-
gations, being based on 450k methylation array data, covered only a
small fraction of the genome and, for example, lack information on
enhancer regulatory elements located outside of promoters.
Although changes of epigenetic modifications due to environ-
mental cues early in life may persist over time, genome-wide data
for studying longitudinal stability of epigenetic patterns in humans
are still missing. Earlier studies have shown evidence for long-
term stability of a limited number of methylation loci. However,
to what extend this is a global trend, or only limited to some
methylation loci is unclear, given the sparse coverage of the
probes from the methylation array. In this study, we address the
following questions: When and where in the genome are epige-
netic marks set by environmental factors? What is the contribution
of the genetic sequence variation to changes in DNA methylation?
Do those changes that are associated with maternal smoking
persist over years or do they appear only transiently? Further-
more, do DNA methylation changes contribute to early program-
ming for disease?
To address these questions, we performed a comprehensive
epigenetic characterization within the LINA mother–child birth
cohort (Herberth et al, 2006, 2011) to dissect the link between envi-
ronmental exposure and epigenetic signals. We first studied the
DNA methylome at single base pair resolution in both children and
their mothers around time of birth and until 4 years after birth. To
decipher the regulatory role of DNA methylation changes associated
with smoking, we performed histone modification ChIP-seq of four
histone modification marks to segment the genome into distinct
regulatory elements and linked the environmentally associated dif-
ferential DNA methylation to transcription as measured by RNA
sequencing. Finally, we show that DNA methylation changes in
conjunction with histone modifications are related to disease devel-
opment later in children’s life.
Results
Maternal smoking is associated with genome-wide DNA
methylation changes that are different between mothers and
their children
A variety of studies has investigated the impact of maternal smoking
on epigenetic changes in newborn children and assessed the stabil-
ity of such epigenetic marks over time. Note that these studies
focused on DNA methylation changes disregarding equally impor-
tant changes on the chromatin level (Joubert et al, 2012; Kupers
et al, 2015; Lee et al, 2015; Richmond et al, 2015). Further, these
studies were performed on the basis of DNA methylation arrays
covering as few as 5% of the entire set of CpG dinucleotides in the
genome located primarily in promoter regions. To overcome the
limitations of presently widely used DNA array methylation arrays
offering only a narrow view on the DNA methylome, we here
followed a radically different discovery and validation strategy
(Fig 1). First, we set out to perform whole-genome bisulfite
sequencing (WGBS) in a set of mothers alongside with their children
and we went further to seek functional support for our findings. For
that, we performed detailed analysis of chromatin configuration
changes encompassing DNA methylation changes and further stud-
ied genome-wide changes in gene expression by RNA sequencing as
a functional readout of the concerted action of DNA methylation
and chromatin configuration changes. Finally, we set out to validate
selected findings in the entire discovery cohort and in an indepen-
dent replication cohort (Fig 1).
To study the impact of maternal smoking on DNA methylation in
both mothers and children, we performed WGBS of whole blood
samples from 32 individuals (maternal blood at 36th week of gesta-
tion for eight smoking mothers and eight non-smoking mothers and
cord blood from their respective child; Table EV1; Fig EV1) at up to
three different time points (for three children from smoking and
three from non-smoking mothers at year one and four, and their
respective mothers at year one; Table EV1; Fig EV1; for overview of
discovery/validation strategy, see Fig 1).
Heterogeneity of whole blood samples may be a possible
confounder in our analysis. Therefore, we excluded the possibility
that differences in cell type composition in the smoking exposed/
non-exposed groups would give rise to DNA methylation changes
by assessing promoter methylation levels from seven lineage mark-
ers reflecting the blood cell type composition in each sample (see
Appendix Supplementary Methods). The analysis showed that the
variation in cellular composition in response to tobacco smoke
exposure was in the range of 1–7% for main blood cell types in
mothers and children with significant reduced granulocyte and
increased B-cell numbers in newborn children from smoking moth-
ers (Table EV2). To exclude differentially methylated regions
(DMRs) that were solely caused by differences in cellular blood
composition between exposed and non-exposed samples, we used a
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threshold of 10% for DMR calling (Fig EV2, Appendix Supplemen-
tary Methods).
Previous studies assessing the impact of smoking on differential
DNA methylation had reported changes for single CpGs in the range
of 1–25% (Zeilinger et al, 2013), indicating that our requirement of
a 10% change represents a conservative threshold. To ensure
consistently different methylation for all samples between groups,
we excluded DMRs by a moderated t-statistics (P > 0.1) and permu-
tation analysis. We thus identified 9743 and 8409 significant
(P < 0.1, DMethylation > 0.1) DMRs in mothers and children,
respectively, in the comparison of the smoking and the non-smoking
individuals at time of birth (Fig 2, Table EV3). Using a random shuf-
fling procedure, we determined that the median false discovery rate
(FDR) level was 12.4% for children and 11.2% for mothers (see
Appendix Supplementary Methods). Note that less than 5% of these
DMRs are covered by CpG probes from the 450k platform. We
finally conducted a FDR analysis based on permutation analysis of
DMRs with subsequent filtering with a range of thresholds for
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Figure 1. Discovery and validation strategy.
To overcome the limitations of presently widely used DNA array methylation arrays offering only a narrow view on the DNAmethylome, we followed a different discovery and
validation strategy. First, we performed whole-genome bisulfite sequencing (WGBS) in a set of mothers alongside with their children. WGBS was carried out in 16 mother–
child pairs, a rather small sample number compared to the typical sizes of epigenetic studies performed on DNA methylation arrays. However, we compensated this potential
drawback by a subsequent comprehensive functional validation. We performed a detailed analysis of chromatin configuration and DNA methylation changes—including
longitudinal stability analyses—and further studied genome-wide gene expression by RNA sequencing as a functional readout of the concerted action of the observed
epigenetic perturbations. In a targeted analysis, we finally validate selected findings in the entire discovery cohort.
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ΔMethylation (1–25%). The obtained results implied that the 10%
cutoff offers an optimal balance between high sensitivity and
medium specificity, which are required when comparing groups of
healthy individuals (see Appendix Supplementary Methods,
Fig EV2).
Beyond environmental factors, the individual genotype also
effects DNA methylation. A single nucleotide polymorphism (SNP)
may destroy the CpG context and thus directly induce differential
DNA methylation in cis by reducing the methylation to 0 (0.5) in
case of a homozygous (heterozygous) CpG-destroying SNP. Further,
SNPs may induce differential methylation by either creating or
disrupting a transcription factor binding site that may affect the level
of DNA methylation (Gutierrez-Arcelus et al, 2013) and may alter
histone modifications (Kasowski et al, 2013; Kilpinen et al, 2013;
McVicker et al, 2013). Given our sample size, we cannot exclude
the fact that in some cases, a differential methylation between the
two groups is due to genotype rather than environmental effects.
To address this issue, we performed SNP calling for each individ-
ual bisulfite sequencing sample using the bisulfite-conversion-aware
SNP caller Bis-SNPs (Liu et al, 2012). To distinguish between envi-
ronmental and genotype-associated differential DNA methylation,
we categorized the DMRs into two groups. Whenever we found a
SNP in the neighborhood ( 5 kb) of a DMR, for which the geno-
type was statistically significantly correlated (at 10% FDR, see
Appendix Supplementary Methods) with methylation of this DMR,
we call this SNP a meQTL-SNP (methylation quantitative trait locus)
for this DMR (see Fig EV3). The corresponding DMR is then termed
a potentially genetically influenced DMR and abbreviated as gDMR
in the following. All DMRs that are not associated with any meQTL-
SNP in their neighborhood are presumably not influenced by the
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Figure 2. Mothers and children harbor a large number of differentially methylated regions between smokers and non-smokers at time of birth.
A Circular representation of DNA methylation levels for mothers (outer circle) and children (inner circle). The height of each bar indicates the methylation change
between the smoking and non-smoking group (dark hue: hypermethylation, light hue: hypomethylation).
B Bar plots represent the number of hypo- versus hypermethylated DMRs for all DMRs and ngDMRs in children and mothers.
C Number of genes predicted to interact with DMRs and ngDMRs. Annotation of allDMRs/ngDMRs according to genomic categories (lower panel).
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genotype and thus termed non-genetically influenced DMR
(ngDMR). Even with this highly stringent definition, we retain about
17–20% (1404/8409 in children and 1953/9743 in mothers) of all
DMRs as ngDMRs that do not have an apparent correlation with the
underlying genetic sequence variation. In summary, we determined
a set of 1404 (1953) DMRs in children (mothers) at time of birth,
which are not related to genotype effects and are likely enriched in
regions for which the environmental cue drives methylation
changes.
DNA methylation changes due to maternal smoking are stably
maintained over years of life
It has been discussed controversially whether DNA methylation
remains stable over longer periods of time or whether there is a
general loss of methylation associated with aging (Heyn et al, 2012;
Raddatz et al, 2013). Previous studies based on 450k data have
shown some examples of CpGs whose methylation levels are stably
maintained over years (Guida et al, 2015; Lee et al, 2015; Richmond
et al, 2015). For example, Richmond et al described 3 CpGs showing
a stable methylation difference related to early tobacco exposure
persisting until the age of 17. Our population-based cohort offers the
unique opportunity to study longitudinal DNA methylation stability
in one and the same individual by comparing two different time
points separated by several years for all CpGs in the genome. We
performed WGBS sequencing for six mothers and their children
(three smoking and three non-smoking; Fig EV1, Table EV1 for
sample overview) 1 year after birth and for the same six children
4 years after birth (for a prototypical example see Fig 3A).
To assess the stability of methylation over time within one indi-
vidual compared to other individuals, we performed hierarchical
clustering of all CpGs located within ngDMRs with coverage > 10
(n = 4682 in children, n = 7857 in mothers). Interestingly, the
methylomes from the same individual at different years (children:
time of birth, 1 and 4 years thereafter; mothers: time of birth and
1 year thereafter) clustered perfectly (Fig EV4A and B) even though
we had removed all genotype-associated gDMRs prior to clustering.
This suggests that a large fraction of specific DNA methylation sites
is stably maintained over at least 4 years in children and over 1 year
in mothers.
Next, we conducted a genome-wide analysis to assess whether
DMRs called at time of birth would remain differentially methylated
1 year after birth. Using the hyper- and hypomethylated regions
determined at time of birth, we assessed whether these regions
remained in their respective methylation state. In 82% (90.4%) of
all ngDMRs in children (mothers), there was still a hypermethyla-
tion and hypomethylation 1 year after birth corresponding the
methylation change observed at time of birth (qualitative stability,
Fig 3B, middle panel). Even with the additional constrain that the
maximum decrease/increase was ≤ 5% of the methylation level at
time of birth, ngDMRs were retained in 73.5% in mothers and in
59.7% in children (quantitative stability, Fig 3B, middle panel). In
children, differential DNA methylation remains at the same level
4 years after birth. Note that the level of stability only increased by
2.6% in mothers and 10.7% in children, respectively, comparing
qualitatively stable ngDMRs with stable gDMRs (Fig 3B lower panel).
Thus, the contribution of the genotype to longitudinal stability of
differential DNA methylation was considerably low. In summary,
maternal smoking is associated with differential DNA methylation
that is persistent in mothers and children up to 4 years after birth.
Tobacco smoke-associated DNA methylation changes correlate
with hypervariable chromatin
To evaluate whether differential DNA methylation correlated with
active or repressive regulatory elements in the genome, we mapped
histone modifications by ChIP-seq for six mothers and their children
for which we already performed WGBS, around year four after birth
(Table EV1). We selected four histone marks to delineate active/
poised elements (H3K4me1 and H3K27ac), separated as enhancers
or promoters based on proximity to a gene’s TSS, as well as repres-
sive elements (H3K9me3 and H3K27me3; Fig 4A). Bivalent states
were defined by co-occurrence of active and repressive marks.
To segment the genome into distinct functional elements,
ChromHMM (Ernst & Kellis, 2012), a Hidden Markov model-based
approach, was trained to cover all 16 possible combinations of the
four histone modifications (Fig 4B) and then applied to segment the
genome of each individual. Note that we started with a fine-grained
definition of 16 chromatin states, but most of the subsequent analy-
sis is done by collapsing the three active and repressive states into
an active and repressive meta-state, respectively. The vast majority
(91% in mothers, 90.8% in children; Table EV4) of the genome
across all individuals was not covered by any of the four histone
marks (background state “void”). The three active/poised enhancer
and active promoter states in children or mothers covered about 4.0
and 3.3%, respectively, of the genome, whereas corresponding
values for the three repressive states were 1.8 and 2.2%. The
remaining part of genomic loci was in a bivalent state and carried
both activating and repressive marks simultaneously.
Next, environmentally associated transitions between chromatin
states were identified from a comparison of non-smoking and smok-
ing individuals (Fig 4C; Table EV5). For mothers, we observed
slightly more transitions to repressive states than to active (29.7%
active versus 41.7% repressive transitions). In children, the vast
majority (43.9%) of transitions were into active states, whereas
transitions into repressive state were much less frequent (17.4%).
This suggests that maternal smoking is associated with a hyperac-
tive chromatin state in their children. While genome-wide chro-
matin state transitions were only statistically significant for
transitions into repressed states in mothers and into bivalent states
in children and in mothers, all of the transitions overlapping with
ngDMRs were statistically significant (Table EV5). These signifi-
cance levels were much more pronounced within ngDMRs, while all
transitions within gDMRs for children reach only borderline signifi-
cance levels. Together with our observation of a significant enrich-
ment (2.4 × in children and 3.0 × in mothers) of variable chromatin
in the ngDMRs, these findings suggest that much of the chromatin
dynamics is strongly linked with differential methylation related to
maternal smoking.
Tobacco smoke exposure is associated with epigenetic
reprogramming of regulatory genomic elements
Only a minor fraction of DMRs co-localized with regions close to
TSS (Fig 2C). Thus, we examined whether the remaining DMRs fall
into active or repressive regulatory genomic elements outside of the
ª 2016 The Authors Molecular Systems Biology 12: 861 | 2016
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TSS. First, we defined active/poised (state 1–3) and repressive (state
12–14) enhancer meta-states (see genome segmentation above and
Appendix Supplementary Methods for details). Note that active
regulatory elements outside of the TSS were considered to be
active/poised enhancers based on their ChIP-seq profile, whereas
active regulatory elements in proximity of TSS were considered as
active promoters. About twice as many DMRs were located in active
regulatory elements outside TSS (“enhancers”) than close to TSS
(“promoters”) both in mothers and in children (Fig 5A and
Table EV7). This trend is observed for all DMRs, but also for
ngDMRs and gDMRs separately. For repressive regulatory elements,
the ratio between DMRs in such elements was approximately 7:1
when comparing regions outside and in proximity of TSS. This
stronger enrichment of differential methylation in regulatory regions
outside TSS was not a mere consequence of the relatively small
genomic size of the TSS region. Rather, by permutation analysis
(see Appendix Supplementary Methods for details), we observed a
highly significant (P = 1.69e-66 for mothers, P = 1.74e-55 for chil-
dren) enrichment of ngDMRs in enhancers both in mothers and in
children (Fig 5A and Table EV7). The enrichment of ngDMRs in
promoters was considerably lower (P = 3.37e-23 for mothers and
P = 6.26e-25 for children). Similarly, ngDMRs in repressive
elements showed a highly significant enrichment outside TSS
(P = 9.33e-16 for mothers and P = 1.89e-18 for children), but
considerably lower significance (P = 1.56e-4 for mothers and
P = 5.07e-3 for children) in promoters. These results suggest that
environmentally associated differential methylation targets enhancer
elements or repressive elements predominantly outside TSS.
Enhancer regions that overlap with DMRs were called differen-
tially methylated enhancers, or DMEs. As described above for
gDMRs and ngDMRs, we distinguished between enhancers in which
differential methylation correlated with a SNP within a  5-kb
window (gDMEs) versus the remaining cases (ngDMEs). The
ngDMEs were mainly located in intragenic regions (62.1% in
A B
Figure 3. Differentially methylated regions show high stability over time.
A Example of an intergenic ngDMR located 8,965 bp away from the TSS of miR-466-6A. Green dots indicate the raw methylation values for non-smoking samples for all
48 CpGs in the region, while black dots indicate the raw methylation of children from smoking mothers. Lines represent smoothed methylation levels. Methylation
differences of 14.5, 13.5, and 12.5%, at time of birth, one year after birth, and four years after birth, respectively, show a strong, quantitative stability of the differential
hypermethylation at this locus.
B Global analysis over all DMRs, ngDMRs, and gDMRs (from top to bottom row) in mothers and children shows stability of methylation using both quantitative criteria
(decrease in absolute mean methylation difference between smokers and non-smokers should not exceed 5%) as well as qualitative criteria (direction of differential
methylation should remain identical irrespective of the absolute methylation change). As expected, genetically determined gDMRs are more stable than their non-
genetically determined counterparts. Still, 90.4% (82–84.1%) of the ngDMRs show longitudinal stability in mothers (children).
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mothers, 59.5% in children; Fig 5A). Comparable numbers were
found for gDMEs. To identify DME target genes, we used various
datasets from genomic interactions based on ChIA-PET assays or
predicted DHS–promoter interactions (see Appendix Supplementary
Methods for details on used interaction data). Interestingly, 93.2%
(88%) of intragenic ngDMEs in children (mothers) are annotated to
target at least one gene outside the host gene in (Table EV8). We
call these elements “commuting” enhancers, as they reside in one
gene but act on various distal genes (Fig 5B). About a third of those
commuting ngDMEs even did not interact with their host gene and
were termed “exclusive commuting enhancers” (Fig 5B). DMEs on
average covered larger genomic regions than non-DMEs (Fig EV5A)
and showed significantly more interactions with predicted
target genes than any other enhancers for intragenic elements
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Figure 4. Chromatin states built from histone marks show specific patterns of transition between non-smokers and smokers..
A Visualization of four histone mark read densities over 249 kb of chromosome 4 representing active marks (H3K27ac and H3K4me1) and repressive marks (H3K27me3
and H3K9me3). This region illustrates examples of (boxed from left to right): a poised enhancer upstream of FGF2 (exhibiting H3K4me1, but lacking the active
signature of H3K27ac); a bivalent promoter of FGF2 (with co-occurring active H3K4me1 and repressive H3K27ac at the promoter); active promoters marks around the
TSS of NUDT6 and SPATA5 (displaying the 2 active marks of H3K27ac and H3K4me1); and repressive marks in the gene body of SPATA5 (H3K9me3), which we observe
in the intron of some expressed genes.
B Chromatin state model derived from all samples representing all possible 16 states. The states were reorganized and named according to biologically relevant
chromatin states representing: lack of signal (state 0, “Void”); active states (states 1–3, in red); bivalent states, showing a combination of both active and repressive
marks, organized by the proportion of the genome that they represent on average (states 4–11, in purple); repressed states (states 12–14, in blue); and a state
representing co-occurrence of all marks, most likely representing genomic amplifications (state 15, “Amplification”).
C Chord diagram of chromatin state transitions in unstable regions of chromatin. The plot shows the transitions from non-smoking to smoking for children and
mothers, where the size of the outer segments represents the amount of chromatin undergoing transitions from one state to another and the width of the ribbons
represents the amount of a single state transiting to another chromatin state. The scale of segment size and ribbon width are comparable between mothers and
children. The outer segments and ribbons are colored according to transition to/from void, active, bivalent, repressed, and amplified as black, red, purple, blue, and
black, respectively. It can be observed that in children, there is a net overall transition to a more hyperactive chromatin state (i.e., gain of twice as much active
chromatin compared to repressed), which is not observed in the mothers who have a more balanced gain of both active and repressive states.
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(P = 5.6e-6/1.2e-4 in children/mothers, Mann–Whitney test) and
marginally significant more for intergenic elements (P = 0.015/
0.037 in children/mothers; Fig EV5B). The results were comparable
when restricting to the subset of enhancers overlapping ngDMRs
(ngDMEs, Fig EV5A and B, right column).
Transcriptional response of epigenetic reprogramming of
regulatory genomic elements
We next set out to understand whether environmentally associated
epigenetic changes would be reflected by differential expression
between the smoking and non-smoking groups in mothers and their
children. Therefore, we performed RNA-seq analysis for 15 mothers
and 12 children at time of birth, for which we already had WGBS
data (Fig EV1 for sample overview). When calling differentially
expressed genes genome wide, we identified only a very small
number (< 10 for children, data not shown) of differentially
expressed genes after correction for multiple testing (10% FDR, BH
correction). To better capture subtle changes of gene expression
when comparing groups of healthy individuals, we sought to first
understand which pathways are enriched for genes targeted by
differentially methylated regions and then to focus our analysis on
genes in those pathways. Given the enrichment of DMRs in active
enhancers and active promoter regions described in the previous
section, we decided to focus on the subset of DMRs, which intersect
these active chromatin elements.
To identify target genes of DMRs, we used various datasets from
genomic interactions based on ChIA-PET assays or predicted DHS–
promoter interactions (see Appendix Supplementary Methods for
details and Table EV3 for assigned genes). Among the pathways
significantly enriched in both mothers and children, we identified
the WNT signaling pathway (Table EV6). We found 62 genes
belonging to the WNT signaling pathway, which are targets of
DMRs in smoking mothers and 48 of such genes in their newborn
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Figure 5. Differential methylation mostly targets distal intragenic regulatory regions.
A Enrichment of DMRs in annotated chromatin elements for children (left) and mothers (right). The bar plot shows the log10(P-value) of the enrichment for ngDMRs
(left bars) and gDMRs (right bars). The percentages indicate the proportion of g/ngDMRs that overlap with chromatin elements of the category.
B Definitions of various enhancer classes: if at least one gene outside the host gene is regulated, we call it a “commuting” enhancer, as it resides in one gene but act on
distal gene(s). When commuting enhancers do not interact with their host gene, we call them “exclusive commuting enhancers”.
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children (Table EV6, Fig EV6). Aberrant WNT signaling has been
reported to be involved in the airway inflammatory response in
healthy smokers and smokers with chronic obstructive pulmonary
disease (COPD) (Wang et al, 2011) and has also been implicated in
a variety of tumors, including lung cancer (Ying & Tao, 2009).
About half of the pathways enriched by genes targeted by regions
that are differentially methylated between the smoking and non-
smoking groups overlapped between children and mothers
(Table EV6A). In contrast, the vast majority of pathways enriched
for target genes of ngDMRs were different for mothers and their chil-
dren (Table EV6B) indicating a clear difference in environmental
modulation of DNA methylation patterns in mothers and children.
About a quarter (n = 22) of all pathways enriched for differential
DNA methylation displayed differential expression for the genes in
those pathways for mothers or children (Fig EV7A). Among all
pathways enriched for DMRs, the WNT pathway in children, but
not in mothers, was the pathway with the highest level of signifi-
cance of differential expression (Fig EV7A). Accordingly, differential
expression of genes in the WNT signaling pathway resulted in a
clear separation between tobacco smoke-exposed/non-exposed
samples (Fig EV7B).
More generally, we explored the functional importance of
genomic regulatory elements by correlating the DNA methylation
level of such elements with transcription of their predicted target
genes. In general, correlation between promoter DNA methylation
and gene expression was poor and typically only 5–10% of DMRs
correlated with gene expression, similar to the observation in a
study of chronic lymphocytic leukemia patients (Kulis et al, 2012).
Within our dataset, also a relatively weak correlation (6–11%)
between DNA methylation and transcription in regions void of any
chromatin mark in both mothers and children was observed
(Fig EV8A). However, we found a high number of predicted target
genes whose expression correlated with DNA methylation in regula-
tory elements. Almost 30% of all differentially methylated repres-
sive regulatory elements showed a positive correlation with
expression of target genes in mothers and 15% in newborn children
(Fig EV8B). Note that the same tendency is observed when restrict-
ing our analysis to ngDMRs (Fig EV8C). On the other hand, 20% of
all differentially methylated enhancers were negatively correlated
with expression of target genes in mothers and 8% in newborn chil-
dren (Fig EV8C). We compared these numbers with the proportion
of significant correlations for DMRs within non-annotated chromatin
regions (“void state”), which we considered as background levels,
and found that these were indeed much lower. Interestingly, the
degree of correlation was much lower at promoters and just above
background (“void state”, Fig EV8B and C). This is in line with
recent observations that enhancer methylation is a better predictor
of gene expression than promoter methylation (Aran et al, 2013;
Blattler et al, 2014). For children, we observe fewer significant
correlations between methylation in any of these categories, likely
reflecting the fact that epigenetic changes in newborns at time of
birth translate on the transcriptional status only later in life. Repeat-
ing the correlation analysis 1 year after birth for children largely
increased the degree of correlation compared to time of birth
(Fig EV8A), suggesting that environmentally associated DNA
methylation in children was already present at time of birth with
increasing impact on transcription in target genes later in life. Taken
together, our integrated analysis of genome-wide DNA methylation,
histone modification, and RNA expression identifies enhancers and
repressive elements outside TSS, whose differential methylation
displays a pronounced correlation with the expression of a large
proportion of target genes.
Validation of tobacco smoke exposure-related differential
methylation in the entire cohort
Based on our analysis of epigenetically deregulated enhancers, we
selected one ngDMR and one gDMR that showed interactions with
more than one target gene (commuting enhancer) to confirm the dif-
ferential DNA methylation observed in the 8 versus 8 comparison in
the entire LINA cohort (n = 471, Fig EV1) by MassARRAY-based
targeted DNA methylation analysis. As a representative example of
a ngDMR in a commuting enhancer region, we chose the ngDMR
with highest significance level when comparing children from smok-
ing to non-smoking mothers, which was located in an intron of
TMEM241 (transmembrane protein 241, Fig 6A). The hypermethy-
lated ngDMR identified in the cord blood was confirmed in the
larger sample set. Concomitant with an increase in maternal urine
cotinine concentrations, DNA methylation levels increase in this
region (Fig 6B). Comparison between WGBS and MassARRAY
suggests that the relatively small effects size observed in the
targeted validation analysis is related to the weaker spread in
methylation values obtained by MassARRAY (Fig 6C).
For the validation of a genetically influenced gDMR, we selected
a commuting enhancer involved in WNT signaling and early
inflammatory response. This commuting enhancer located in the
intron of GFPT2 (glutamine-fructose-6-phosphate transaminase 2)
was previously annotated by ChIA-PET (Li et al, 2012) as an
intronic enhancer interacting with a large number of target genes
including c-Jun N-terminal kinase 2 (JNK2; also known as MAPK9)
(Fig 6D). Further inspection of SNPs in a  5-kb window of the
“JNK2 commuting enhancer” revealed that the DNA methylation
level was correlated with SNP rs55901738 located within this DMR
(Fig EV9A). This C>A polymorphism is interesting since it does not
occur in a CpG context, which would result in direct loss of DNA
methylation. Rather, this polymorphism is predicted to create a new
binding site for the transcription factor Oct4. According to our RNA
sequence data, Oct4 is expressed in both children and mothers in
our cohort. Since the presence of an Oct4 binding site was related to
hypomethylation (Zimmerman et al, 2013), the presence of such a
binding site may contribute to the decrease of DNA methylation in
individuals with the C>A genotype. In both the LINA discovery
cohort (Fig 6E) and the LISA validation cohort (Fig EV9B), DNA
methylation of the JNK2 commuting enhancer correlates with the
genotype. Notably, the majority of children of smoking mothers in
the LINA discovery cohort and of tobacco smoke-exposed children
in the LISA validation cohort display a C/A or A/A genotype in this
position giving rise to an overall reduced methylation of the JNK2
commuting enhancer in smoking individuals (significant for mater-
nal cotinine level > 350 lg/g creatinine and for children’s urine
cotinine levels > 40 lg/g creatinine; Table EV9A/B).
In cord blood, a decrease of DNA methylation in the JNK2
enhancer was observed that was related to maternal urine cotinine
levels (Fig 6F). This relation points to a combined effect with the
genotype predisposing for an environmentally triggered epigenetic
deregulation of JNK2. This hypothesis is corroborated by our
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findings that in the LISA cohort, the urine cotinine levels in children
also reversely correlated with JNK2 enhancer methylation (Fig
EV9C). To test whether DNA demethylation of the JNK2 enhancer is
causatively related to tobacco smoke exposure, we applied an
in vitro model based on peripheral blood mononuclear cells
(PBMCs). Following a four-day exposure period with a cigarette
smoke extract, we observed a decrease in enhancer methylation of
11.1%  7.6% (SD) in seven out of eight donors tested, an effect
comparable to the reduction in DNA methylation in relation to urine
cotinine levels (Fig EV9D).
Link between “commuting enhancer” deregulation and
phenotype development
Finally, we aimed to elucidate whether differential DNA methylation
in commuting enhancers was linked to a phenotype in the children.
Since the function of TMEM241 is yet unknown, we focused this
follow-up analysis on the JNK2 enhancer region. JNK2 is a member
of the WNT signaling cascade, which has been implicated in a vari-
ety of tobacco smoke-induced lung diseases including COPD and
lung cancer (Ying & Tao, 2009; Wang et al, 2011). Therefore, dereg-
ulation in the JNK2 enhancer might contribute to the development
of adverse respiratory symptoms, although a link between lung
disease development and JNK2 has not yet been described. Maternal
smoking during pregnancy has been described as one of the
contributing factors of impaired lung function and an increased risk
of asthma and wheeze development in children (Burke et al, 2012).
Wheezing, a whistling sound produced in the airways during
breathing, is widely recognized as an early indicator of such an
impaired lung function affecting a considerable number of children
already in the first years of life. About 22–46% of children showing
wheezing symptoms in early childhood are diagnosed with asthma
later in life (Martinez et al, 1995).
We observed a hypomethylation in the JNK2 enhancer region
related to tobacco smoke exposure in both mothers and newborn
children (Table EV3). Additionally, histone modifications in this
enhancer were also clearly linked to the smoking status. While in
non-smoking mothers and their children a repressed or void chro-
matin state was present, smoking was associated with an active
chromatin state in this region (Fig EV10A). In contrast, histone
modifications in the promoter of JNK2 were indicative of an active
state in all samples irrespective of their smoking status.
To further characterize the functional consequences of DNA
hypomethylation in this enhancer region, we evaluated its
association with JNK2 transcription. DNA methylation and
transcription correlated slightly but significantly in the entire cohort
already at time of birth (R = 0.11, P = 0.044). Separating children
from non-smoking (R = 0.06, P = 0.56) and smoking (R = 0.46,
P = 0.034) mothers revealed that the overall significance was driven
by the small subpopulation of children from smoking mothers
(Fig EV10B) further supporting a combined effect of genotype and
environment in transcriptional regulation of JNK2. In four-year-old
children, the transcription of JNK2 is again slightly but significantly
correlated with JNK2 enhancer methylation (R = 0.16, P = 0.04).
Furthermore, blood levels of the pro-inflammatory cytokine IL-8, a
downstream target of JNK2, correlated with JNK2 expression
(Fig EV11A and B) (Holtmann et al, 1999; Hoffmann et al, 2002).
Moreover, JNK2 transcription as well as IL-8 protein expression was
significantly elevated in children developing wheezing symptoms
from year four on compared to those who never showed any
wheezing or other respiratory symptoms (Fig EV11B).
Similar to what we observed when comparing children of smok-
ing and non-smoking mothers, children developing wheezing symp-
toms after the age of four (late-onset wheeze) show a DNA
hypomethylation of the JNK2 enhancer. The association between
JNK2 enhancer DNA demethylation and late-onset wheeze was
apparent already at birth (DMethylation = 17%) and remained stable
until the age of four (DMethylation = 14%) (Fig 7A). To control for
possible confounding factors influencing the risk of wheeze (gender,
number of siblings, the presence of a cat in the household, parental
history of atopy, smoking during pregnancy, and school education),
we performed a logistic regression analysis. These results confirmed
that DNA hypomethylation in the JNK2 enhancer region was signifi-
cantly associated with a higher risk of wheeze (Fig 7A). The result-
ing odds ratio (OR) of 1.40 implicates a risk increase of 40% per
10% methylation loss. Thus, children with full loss of methylation in
this region at time of birth would have an almost 400% increase in
risk to develop wheezing symptoms later in life. In the independent
validation cohort (LISA), we confirmed that loss of DNA methylation
in the JNK2 enhancer is associated with an increased risk for the
development of wheezing symptoms in four-year-old children with
an adjusted OR of 1.48 (CI:1.07–2.05; Fig 7A).
To further assess the role of JNK2 in the development of lung
disease, we investigated the effect of JNK2 deficiency in a mouse
asthma model. Sensitization and challenge of JNK2/ mice with
ovalbumin (OVA) resulted in markedly reduced airway inflamma-
tion shown by substantially less inflammatory infiltrates in the
peribronchial and perivascular regions and a decreased mucous
◀ Figure 6. Validation of two representative examples of commuting enhancers.A Extended locus of a commuting enhancer overlapping a ngDMR in the TMEM241 intron.
B The hypermethylated DMR in the enhancer region identified in the cord blood of prenatally exposed children was confirmed by MassARRAY (n = 471). The results
show that concomitant with an increase in maternal cotinine levels, DNA methylation increases in this region.
C Box plots compare methylation in the TMEM241 DMR evaluated by WGBS and by MassARRAY, respectively, for the same eight individuals. This comparison suggests
that the relatively small effects size observed in the MassARRAY validation seems to be in part related to the weaker spread in methylation values obtained by this
method.
D Extended locus of the JNK2 enhancer, showing all predicted target genes by ChIA-PET and promoter-DHS interaction data.
E A clear negative correlation between the genotype of rs55901738 (located inside the JNK2 DME) and the methylation level in this locus was observed in the discovery
cohort (N = 181/203/56).
F The hypomethylated gDMR within the JNK2 enhancer region was similarly validated by MassARRAY in the entire cohort. Loss of DNA methylation in this region
depends on maternal urine cotinine levels and decreases steadily with an increase in maternal urine cotinine concentrations. For children of heavy smoking mothers
(cotinine level > 350 µg/g creatinine) we observe a methylation difference of over 10% compared to non-smoking mothers.
Data information: (B, C, E, F) Box plots visualize 25th to 75th percentile, line indicates the median, whiskers represent the non-outlier range.
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gland hyperplasia in the airway epithelium compared to OVA-
sensitized wild-type (WT) animals (Fig 7B). Accordingly, the
accumulation of eosinophils, lymphocytes, and macrophages in the
bronchoalveolar lavage (BAL) fluid of JNK2/ mice was clearly
diminished (Fig 7C). Furthermore, the methacholine-induced airway
hyperreactivity (AHR), measured as lung resistance (RL), was
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Figure 7. JNK2 is linked to lung disease.
A In both the discovery and the validation cohort, we show that loss of DNA methylation in the JNK2 enhancer is associated with an increased risk for the
development of wheezing symptoms in four-year-old children. Odds ratios are calculated using logistic regression models adjusted for gender, number of siblings,
the presence of a cat in the household, parental history of atopy, school education, and smoking during pregnancy (adj. OR). In 4-year-old children, regression
models were additionally adjusted for postnatal smoking (infantile urine cotinine concentrations, box plots vizualize 25/75 percentile and median, whiskers
represent non-outlier range).
B–D JNK2 knockdown leads to a diminished asthma response in OVA-sensitized mice. (B) HE- and PAS-stained lung sections of OVA-sensitized JNK2/ mice show
reduced cell infiltration and mucous gland hyperplasia compared to wild-type controls. (C) The number of eosinophils, lymphocytes, and macrophages in BAL fluid
is significantly lower in JNK2/ mice, (D) which is accompanied by a decrease in AHR compared to OVA-sensitized WT mice (*P < 0.05 by Student’s t-test, data are
shown as mean  SD (n = 10–15) of three independent experiments).
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significantly reduced in JNK2/ mice compared to WT controls
(Fig 7D). Therefore, JNK2 deficiency leads to a diminished asthma
phenotype, which supports the findings in our cohort confirming
that JNK2 is directly involved in the development of lung disease.
Taken together, we link loss of DNA methylation in the JNK2
commuting enhancer with the occurrence of impaired lung function
mediated through differential expression of its target gene JNK2, a
thus far unknown key player in the development of lung disease.
Discussion
How prenatal exposure to smoking and other factors affect the
newborn’s epigenome and to which extent the resulting changes are
stably maintained has been a central question for epigenetic medical
research. Here, we acquired comprehensive genome-wide maps of
DNA methylation changes linked to smoking and combined them
with histone modification profiles and gene expression analysis.
This represents an entirely different approach compared to previous
EWAS focusing exclusively on methylation changes of a smaller
subset of all CpGs genome wide. We demonstrated for the first time
within a longitudinal human cohort study that in utero exposure to
tobacco smoke affects the global epigenome of both mothers and
children in regulatory elements and that this epigenetic modulation
is stably maintained. Interestingly, while the unborn child is exposed
to similar environmental challenges as its mother, the response on
the DNA methylation and histone modification level is quite distinct.
Apart from potential age-related epigenetic pattern, this could be due
to the specificity of the placental barrier, which potentially leads to
higher exposure of the unborn child to components of tobacco
smoke as nicotine than the mother (Luck et al, 1985).
DNA methylation and enhancer activity are linked as demon-
strated in a number of studies (Aran & Hellman, 2013),(Hon et al,
2013; Mukamel & Tanay, 2013). Notably, a preference of tissue
specific DMRs at distal cis-regulatory elements was reported with
some of these enhancers being dormant in adult tissues but active
during embryonic development (Hon et al, 2013). The mechanistic
details of the cross talk between DNA methylation, histone modifi-
cations, and enhancer RNA transcription are currently unclear but
might involve links between DNA and histone modifications
(Bergman & Cedar, 2013) as well as modulation of transcription
factor binding due to DNA (hydroxy)methylation-directed nucleo-
some positioning (Teif et al, 2014). It should be noted that our
results on the functional relevance of deregulated epigenetic signal-
ing at intragenic enhancers and its link to disease risk could only be
obtained from individualized epigenome annotations in addition to
cell line-derived maps like histone modification ChIP-seq and DNase
I hypersensitivity data from consortia like ENCODE or Roadmap.
Prenatal tobacco smoke exposure has been identified as one of
the important risk factors for impaired lung function later in chil-
dren’s life. Accordingly, we specifically focused on potential links
between DNA methylation changes and the development of respira-
tory diseases in children. Supported by our in vitro results, our
epidemiological data indicate a combined impact of tobacco smoke
and the genotype on DNA methylation of the JNK2 commuting
enhancer located in the GFPT2 gene and show that DNA
methylation loss and gain of activating histone marks within this
commuting enhancer correlates with an increase of JNK2 gene
expression. Loss of DNA methylation in the JNK2 enhancer was
furthermore associated with an increased risk for children to develop
wheezing symptoms later in their life. A mouse asthma model
corroborated the functional relevance of our epigenome analysis.
The JNK2/ mice exhibited markedly reduced airway inflammation
and airway hyperreactivity compared to WT controls suggesting a
direct role for JNK2 in the development of lung disease. Further
evidence for the regulatory role of JNK2 comes from a recent study
demonstrating enhanced airway inflammation and impaired lung
function due to a JNK2-triggered loss of the regulatory function of
naturally occurring regulatory T cells (Joetham et al, 2014).
Regulatory T cells were identified as important regulators of allergic
lung diseases as they are recruited from the blood to allergen-
challenged lungs inhibiting asthmatic responses. Since cross talk
between activated immune cells from the blood and lung tissue was
shown to contribute to the development and exacerbation of the
local inflammatory response in the lung tissue (O’Donnell et al,
2006), changes of JNK2 activity in blood cells are likely to reflect
corresponding changes in cells infiltrating inflamed lung tissue.
For the first time, we distinguished between genotype- and envi-
ronment-related effects on the epigenome in a genome-wide
approach. We showed that in both mothers and children, a signifi-
cant proportion of the DMRs appear to be driven by nearby geno-
type effects (7005/8409 in children, 7790/9743 in mothers).
However, this also means that around 20% of the DMRs are not
affected by nearby SNPs, and might be the result of environmental
exposure to tobacco smoke. Interestingly, the enrichment of this set
of ngDMRs in enhancers is considerably more significant than the
enrichment seen by considering all DMRs, indicating that ngDMRs
indeed represent a separate class of elements. We also showed that
differential methylation in annotated chromatin regions has an
effect on gene expression, depending on the type of chromatin
marks present in the locus. In particular, differential methylation in
enhancer regions correlates negatively with expression, more than
in promoter regions or in void regions. Hence, modulation of the
enhancer activity through variable DNA methylation conditioned by
non-genotype effects leads to a differential regulation of down-
stream genes (Aran et al, 2013; Blattler et al, 2014). The fact that
enhancers overlapping with DMRs have more target genes
compared to the full set of enhancers indicates that differential
methylation is targeted at regulatory hubs. While histone modifi-
cations might also be under the control of the genotype (Kasowski
et al, 2013; Kilpinen et al, 2013; McVicker et al, 2013), our focus
was specifically on alterations in the DNA methylation pattern.
Although we focused our validation experiments on enhancer
regions overlapping with DMRs, we do not claim that only epigenetic
deregulation in enhancer regions are of biological relevance. We
decided to focus on enhancers to emphasize the fact that regulatory
regions are more frequently epigenetically deregulated by tobacco
smoke exposure than other genomic regions. However, DMRs in
other genomic regions could potentially also be related to a particu-
lar phenotype by enhancer-independent mechanism. A prominent
example is the hypomethylated cg19859270 in the GPR15 gene body
found in active and former smokers with a delta methylation of only
1–2%. As we showed in a previous study (Bauer et al, 2015), this
very minor methylation change, identified in whole blood DNA
samples, is related to the expansion of a small subset of GPR15
expressing T cells potentially involved in lung inflammation. This
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example shows that even very minor methylation changes observed
in whole blood samples might be of strong biological relevance.
Non-genetically associated differential DNA methylation was
shown to be faithfully conserved over years in children’s life. In the
LINA cohort, only a relatively small number of children were
exposed to tobacco smoke prenatally but not after birth. In many
instances, however, children prenatally exposed to tobacco smoke
remain exposed after birth. Accordingly, it was difficult to evaluate
whether persistence of this environmental exposure after birth,
albeit at a largely reduced effective concentration, could contribute
to the high stability of induced DNA methylation changes in chil-
dren over years after birth. Another important question is if other
maternally or paternally transferred environmental challenges such
as psychological stress, pollutants, and nutrition that are also moni-
tored as part of the LINA study would have synergistic or indepen-
dent effects on the children’s epigenome. Thus, we anticipate that
further exciting links between environmental factors and epigenetic
deregulation will be revealed from the LINA dataset in continuation
of the approach introduced here.
Apparently, the design of our study differs from conventional
EWAS starting with a large sample set but focusing solely on DNA
methylation changes in preselected CpG sites covering at best 5% of
the genome. Although our WGBS approach was based initially only
on 8 versus 8 mother–child pairs, we were able to confirm differen-
tial methylation at single CpG sites identified in those large EWAS
(e.g., AHRR cg05575921, DMethylation = 9.8%, P-value=0.007;
MYO1G cg12803068, DMethylation = 12.1%, P-value = 0.038; GFI1
cg18146737, DMethylation = 16.9%, P-value = 0.05). Even though
WGBS is not yet feasible for larger cohorts with hundreds or thou-
sands of individuals, results obtained on a smaller sample set are
representative as shown in the validation analysis (TMEM241 and
JNK2 enhancer). The major advantage of this WGBS-based
approach is the opportunity to study important genomic regions
beyond promoters largely covered by DNA methylation arrays. Note
that regulatory elements in particular enhancers are largely missing
on these commonly used arrays. Thus, we were able to show for the
first time that environmental exposure deregulates particularly regu-
latory regions of the genome. Moreover, by combining DNA methy-
lation, histone modification, and gene expression analyses, we
showed that epigenetic perturbation by environmental exposure is
functionally translated and potentially linked to phenotype develop-
ment. Thus, the depth and breadth of our analyses goes well beyond
any earlier environmental epigenetics study.
Materials and Methods
Description of the cohorts
For this study, two population-based cohorts were employed. As
discovery cohort, we used the prospective mother–child cohort,
LINA (Lifestyle and environmental factors and their Influence on
Newborns Allergy risk). For this cohort, 629 mother–child pairs
(622 mothers and 629 children; seven twins) were recruited
between May 2006 and December 2008 in Leipzig, Germany, to
investigate the pre- and postnatal influences of lifestyle and
environmental factors on the immune system of the newborn and
the disease risk of the child later in life. Mothers suffering from
immune or infectious diseases during pregnancy were excluded
from the study. Blood samples were obtained from mothers at the
36th week of gestation and cord blood at delivery (for details see
Herberth et al, 2010, 2011). Longitudinal blood samples at year one
till five were taken from both children and mothers (Fig EV1).
During pregnancy, standardized questionnaires were recorded, as
well as at each child’s birthday (see Appendix Supplementary Meth-
ods). All questionnaires were self-administered by the parents.
Maternal smoking was determined based on the questionnaire
response and urine cotinine levels > 100 lg/g creatinine (see
Appendix Supplementary Methods). During annual clinical visits,
blood samples were obtained from children and mothers. Participa-
tion in the study was voluntary, and informed consent was obtained
from all participants. The study was approved by the Ethics
Committees of the University of Leipzig (046-2006, 160-2008, 160b/
2008, 144-10-31052010, 113-11-18042011).
As validation cohort, we used a further prospective birth cohort,
LISA (Life style–Immune System–Allergy). For LISA, a total of 2443
healthy neonates born in the German cities Munich and Leipzig
were recruited between December 1997 and January 1999. The
study design, blood sampling, and the questionnaire items used for
the description of children’s disease outcomes and confounding
variables were comparable between LINA and LISA (Lehmann et al,
2002). The study was approved by the Ethics Committees of the
University of Leipzig and Munich (206/2003). Written informed
consent was obtained from the parents of all children.
Whole-genome bisulfite sequencing
Whole blood samples were obtained from eight smoking and eight
non-smoking mother–child pairs (see Appendix Supplementary
Methods and Fig EV1). Libraries were prepared using the TruSeq
DNA Sample Prep Kit v2-Set A (Illumina Inc., San Diego, CA, USA)
according to the manufacturer’s instructions. Adapter-ligated
libraries were treated with bisulfite and PCR-amplified (see
Appendix Supplementary Methods and Table EV10). Sequencing on
HiSeq2000 (101-bp paired-end) was performed using standard Illu-
mina protocols and the 200-cycle TruSeq SBS Kit v3 (Illumina Inc.,
San Diego, CA, USA).
DMR calling and annotation
The bsseq v0.10 package (Hansen et al, 2012) for R statistical
software v3.0.0 was used to smooth bisulfite sequencing data and
call candidate DMRs. Because of our high average CpG coverage,
we performed smoothing on a small window size with minimum
11 CpGs (ns = 11) and a minimum total width of 1 kb (h = 500),
breaking the smoothing if gaps between CpGs exceeded 2 kb
(maxGap = 2000). We calculated average raw methylation levels
of each DMR and sample and performed a moderated t-test as in
SAM statistics (significance analysis of microarrays, Tusher et al,
2001; R-package siggenes v1.36.0, Schwender, 2012) to assign
P-values to each of the DMR. SAM P-values are low for DMRs
that are consistently different between the groups. Based on the
P-value (pSAM < 0.1) and the level of mean methylation changes
(ΔMethylation > 0.1 in both raw and smoothed data), we filtered
and ranked the DMR list for downstream analyses. We conducted
false discovery rate analysis (FDR) based on permutation analysis
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of DMRs before and after SAM filtering with thresholds for
ΔMethylation (1–25%). The obtained results suggest that a cutoff of
10% offers an optimal balance between high sensitivity and
medium specificity, which is required when comparing groups of
healthy individuals (see Appendix Supplementary Methods).
Initial genomic annotation of DMRs to the nearest TSS was
obtained with the annotate Peaks script of the HOMER tools soft-
ware package (Heinz et al, 2010) to genome version hg19. For
calculating the significance of enrichment of DMRs in certain
regions of interest (ROIs), we performed a random shuffling
approach. First, regions of the same size as the DMRs were
randomly sampled from the whole genome. In a second step, the
number of overlaps of these random regions with the ROIs was
calculated using BEDTools (Quinlan & Hall, 2010). This procedure
was repeated 1000 times to determine the empirical null distribu-
tion. This empirical distribution was used to estimate the one-sided
upper-tail P-values for enrichment. We calculated the fold change as
the number of overlaps of the DMRs with the ROIs divided by the
average number as determined by the randomizations.
ChIP-seq assays and peak calling
ChIP-seq of histone modifications was performed in six mother–
child pairs including three smoking and three non-smoking mothers
and their children using standard ChIP-seq protocols (see
Appendix Supplementary Methods). Regions of the genome exhibit-
ing significant enrichment of histone modifications were identified
using SICER v1.3 (Zang et al, 2009) and MACS v 1.4.1 (Zhang et al,
2008). Reads were aligned as outlined by Feng et al (2012). MACS
was used to call peaks setting the histone modification alignment
file as the treatment and the H3 SAM file as the control files. A
threshold of P ≤ 1e-5 was used to identify significant peaks. Addi-
tional peaks were called using SICER on all histone modifications
with H3 as a control, removing all duplicate reads. The MACS and
SICER peak calls were merged to maximize sensitivity. The peak
calling summary is shown in Table EV1B.
Genome segmentation and chromatin annotation
The chromatin was segmented and annotated using a multivariate
Hidden Markov Model, ChromHMM (Ernst & Kellis, 2012). We
trained a ChromHMM model over the four histone modification
marks (H3K4me1, H3K27ac, H3K27me3, and H3K9me3) across all
samples, which was subsequently used to segment the genome of
each individual. The model was learned using the merged peak calls
from MACS and SICER as the binarized input and allowing for a
maximum of 400 iterations. We generated models with 5–16 states
and decided to use 16 states as this captures all combinations of the
four histone modifications so that rare chromatin states are also
represented (Fig 4B). Each chromatin state was labeled based on a
biologically interpretable name corresponding to the co-occurring
histone marks. Chromatin states were merged over subsets of
the data covering mothers, children, and their smoking and
non-smoking subsets, where at least two samples had a genomic
locus labeled to be of a particular chromatin state. To annotate
promoter-associated marks, we identified all features overlapping
with a RefSeq TSS, directly neighboring the overlapping feature with
the TSS and its direct neighbors, and all features 400 bp from these,
and annotated them as “TSS associated”. The remaining was labeled
as “not TSS associated”. Active regulatory elements were identified
by merging three active states (states 1, 2, and 3, see Fig 4) into a
common meta-state. Active regulatory elements, which were not
TSS associated, were defined as enhancers. A repressed meta-state
was defined by merging states 12, 13, and 14.
RNA sequencing and analysis
RNA-seq libraries were built using the Illumina TruSeq RNA Sample
Preparation Kit v2 (Illumina Inc., San Diego, CA, USA) according to
the manufacturer’s instructions. The final libraries were validated
using Qubit (Invitrogen) and Agilent 2100 Bioanalyzer (Agilent
Technologies). Sequencing on Illumina HiSeq2000/2500 (101-bp
paired-end) was performed using standard protocols and the 200-
cycle TruSeq SBS Kit v3 (see Appendix Supplementary Methods).
RNA sequences were aligned to hg19 reference genome using the
STAR alignment software (Dobin et al, 2013), with Gencode v19 as
the transcriptome annotation. Counts of reads mapped to exons
were estimated by htseq-count (Anders et al, 2015). For down-
stream analysis, raw counts were normalized by the Voom method
in the limma package (Smyth, 2005) and the Combat method in the
sva package (Jeffrey et al, 2014) was applied to correct for possible
batch effects.
Correlation analysis between DMRs and expression of
target genes
We calculated the Spearman correlation between the mean DMR
methylation and the target gene expression. For DMRs containing
multiple CpG sites, mean methylation across CpG sites was calcu-
lated per sample. DMRs were first intersected with different chro-
matin states inferred from ChIP-seq data. For DMRs overlapping
with void or TSS-associated states, the closest gene was used as the
target gene. For DMRs overlapping with repressed or non-TSS-
associated states, we used the predicted target gene from public
interaction datasets (ChIA-PET and promoter–DHS interactions, see
Appendix Supplementary Methods). For DMEs (DMRs overlapping
with enhancers), we used the union of the target genes of the DMR
and the overlapping enhancer. For each DMR-target gene pair, the
significance of the correlation was calculated by the Spearman
correlation test and the cutoff for significance was set to 0.05.
Validation by MassARRAY methylation analysis and qPCR
Quantitative DNA methylation analyses of the enhancers in the
TMEM241 and GFPT2 genes was performed using Sequenom’s
MassARRAY platform. Bisulfite-treated libraries were PCR-
amplified. The PCR product was in vitro transcribed and cleaved by
RNase A using the EpiTyper T Complete Reagent Set (Sequenom,
Hamburg, Germany) and subjected to MALDI-TOF mass spectro-
metry analysis to determine methylation patterns as previously
described (Ehrich et al, 2008). DNA methylation standards (0, 20,
40, 60, 80, and 100% methylated genomic DNA) were used to
control for potential PCR bias.
For qPCR, total RNA was prepared from fresh cord blood by using
peqGold RNA Pure (peqlab, Erlangen, Germany) and from blood
collected in PAXgene Blood RNA Tube of year four by PAXgene
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Blood RNA Kit (Qiagen, Hilden, Germany), according to manufac-
turer’s instructions. The cDNA synthesis was carried out with 5 lg
of RNA by using ImProm-IITM Reverse Transcription System
(Promega, Mannheim, Germany). Gene expression was measured
using the 96.96 Dynamic Array or FLEXsix Integrated Fluidic Circuits
(IFCs) (Fluidigm, San Francisco, CA, USA). Intron-spanning primers
were designed (see Appendix Supplementary Methods). Gene
expression values were determined by using the 2ΔΔCT method
(Livak & Schmittgen, 2001) with GAPD and GUSB, as reference genes
and normalized to the lowest measured value.
Murine asthma model
JNK21/ mice (C57BL/6 background) and control wild-type mice
(WT) were bred and maintained at the animal facility of the Tokyo
Medical University. Experiments were approved by the Ethical
Committee of Animal Experiments of the Tokyo Medical University.
JNK2/ and C57BL/6J WT mice were sensitized and challenged
with ovalbumin (OVA) and assayed for airway inflammation and
airway hyperreactivity (AHR) as described before (Takada et al,
2013) and in the Appendix Supplementary Methods.
Data availability
Next-generation sequencing data have been deposited at the Euro-
pean Genome-phenome Archive (EGA, http://www.ebi.ac.uk/ega/)
hosted by the EBI, under accession numbers EGAS00001000455.
Expanded View for this article is available online.
Acknowledgements
We would like to thank Stephan Wolf and Nicole Diessl at the DKFZ Genomics
and Proteomics Core Facility for the excellent technical support and expertise.
Further, we are grateful to Marion Bähr and Monika Helf who provided
outstanding support in MassARRAY validation. We acknowledge very helpful
discussions of cell lineage markers with Daniel Lipka and Soo-Zin Kim-Wanner
and critical discussion of the manuscript with Christopher C. Oakes. We
cordially thank the participants of the LINA study as well as Beate Fink, Anne
Hain, Livia Sztraka, and Melanie Nowak for their excellent technical assistance
and fieldwork. We are grateful to Martin von Bergen for providing urine cotinine
concentrations. We also thank Pavel Komardin (Data management group at
eilslabs) for the organization and implementation of all tasks involved in data
submission to EBI. This work was supported by the Helmholtz cross program
activity on Personalized Medicine (iMed) and the BMBF-funded eMED network
PANC-STRAT (FKZ: 01ZX1305A). Major support came from the German Cancer
Research Center—Heidelberg Center for Personalized Oncology (DKFZ-HIPO).
Author contributions
MBa, ST, LT, DW, J M, OM MW, GH, MiS, CG, SWi, RE, and IL performed and/or
coordinated experimental work. TB, NI, CH, LG, MBi, ZG KG, QW, SR, MBa, GH,
ST, MaS, KR, and CL performed data analysis. MBo, SR, GH, UR-K, KJ, and IL
collected data and provided proband materials. ET and JM performed the
mouse experiments. TB, ST, NI, MBa, LG, QW, GH, LT, DW, CP, KJ, TP, SR, ZG, KR,
C H, RE, and IL prepared the initial manuscript and figures. HS, CP, CH, RE, and
IL provided project leadership. All authors contributed to the final manuscript.
Conflict of interest
The authors declare that they have no conflicting interest.
References
Aguilera O, Fernandez AF, Munoz A, Fraga MF (2010) Epigenetics and
environment: a complex relationship. J Appl Physiol 109: 243 – 251
Anders S, Pyl TP, Huber W (2015) HTSeq — a Python framework to work
with high-throughput sequencing data. Bioinformatics 31: 166 – 169.
Aran D, Hellman A (2013) DNA methylation of transcriptional enhancers and
cancer predisposition. Cell 154: 11 – 13
Aran D, Sabato S, Hellman A (2013) DNA methylation of distal regulatory sites
characterizes dysregulation of cancer genes. Genome Biol 14: R21
Bauer M, Linsel G, Fink B, Offenberg K, Hahn AM, Sack U, Knaack H, Eszlinger
M, Herberth G (2015) A varying T cell subtype explains apparent tobacco
smoking induced single CpG hypomethylation in whole blood. Clin
Epigenetics 7: 1 – 11
Bergman Y, Cedar H (2013) DNA methylation dynamics in health and disease.
Nat Struct Mol Biol 20: 274 – 281
Blattler A, Yao L, Witt H, Guo Y, Nicolet CM, Berman BP, Farnham PJ (2014)
Global loss of DNA methylation uncovers intronic enhancers in genes
showing expression changes. Genome Biol 15: 469
Breton CV, Byun HM, Wenten M, Pan F, Yang A, Gilliland FD (2009) Prenatal
tobacco smoke exposure affects global and gene-specific DNA
methylation. Am J Respir Crit Care Med 180: 462 – 467
Brown AS, Susser ES, Lin SP, Neugebauer R, Gorman JM (1995) Increased
risk of affective disorders in males after second trimester prenatal
exposure to the Dutch hunger winter of 1944–45. Br J Psychiatry 166:
601 – 606
Burke H, Leonardi-Bee J, Hashim A, Pine-Abata H, Chen Y, Cook DG, Britton
JR, McKeever TM (2012) Prenatal and passive smoke exposure and
incidence of asthma and wheeze: systematic review and meta-analysis.
Pediatrics 129: 735 – 744
Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P,
Chaisson M, Gingeras TR (2013) STAR: ultrafast universal RNA-seq aligner.
Bioinformatics 29: 15 – 21
Ehrich M, Turner J, Gibbs P, Lipton L, Giovanneti M, Cantor C, van den Boom
D (2008) Cytosine methylation profiling of cancer cell lines. Proc Natl Acad
Sci USA 105: 4844 – 4849
Ernst J, Kellis M (2012) ChromHMM: automating chromatin-state discovery
and characterization. Nat Methods 9: 215 – 216
Feng J, Liu T, Qin B, Zhang Y, Liu XS (2012) Identifying ChIP-seq enrichment
using MACS. Nat Protoc 7: 1728 – 1740
Guida F, Sandanger TM, Castagne R, Campanella G, Polidoro S, Palli D, Krogh
V, Tumino R, Sacerdote C, Panico S, Severi G, Kyrtopoulos SA, Georgiadis P,
Vermeulen RC, Lund E, Vineis P, Chadeau-Hyam M (2015) Dynamics of
smoking-induced genome-wide methylation changes with time since
smoking cessation. Hum Mol Genet 24: 2349 – 2359
Gutierrez-Arcelus M, Lappalainen T, Montgomery SB, Buil A, Ongen H,
Yurovsky A, Bryois J, Giger T, Romano L, Planchon A, Falconnet E, Bielser D,
Gagnebin M, Padioleau I, Borel C, Letourneau A, Makrythanasis P,
Guipponi M, Gehrig C, Antonarakis SE et al (2013) Passive and active DNA
methylation and the interplay with genetic variation in gene regulation.
eLife 2: e00523 .
Hansen KD, Langmead B, Irizarry RA (2012) BSmooth: from whole genome
bisulfite sequencing reads to differentially methylated regions. Genome
Biol 13: R83
Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C,
Singh H, Glass CK (2010) Simple combinations of lineage-determining
transcription factors prime cis-regulatory elements required for
macrophage and B cell identities. Mol Cell 38: 576 – 589
Molecular Systems Biology 12: 861 | 2016 ª 2016 The Authors
Molecular Systems Biology Epigenetic reprogramming in regulatory elements Tobias Bauer et al
16
Published online: March 24, 2016 
Hemminki K, Chen B (2006) Parental lung cancer as predictor of cancer risks
in offspring: clues about multiple routes of harmful influence? Int J Cancer
118: 744 – 748
Herberth G, Daegelmann C, Weber A, Roder S, Giese T, Kramer U, Schins RP,
Behrendt H, Borte M, Lehmann I (2006) Association of neuropeptides with
Th1/Th2 balance and allergic sensitization in children. Clin Exp Allergy 36:
1408 – 1416
Herberth G, Heinrich J, Roder S, Figl A, Weiss M, Diez U, Borte M, Herbarth O,
Lehmann I (2010) Reduced IFN-gamma- and enhanced IL-4-producing
CD4 + cord blood T cells are associated with a higher risk for atopic
dermatitis during the first 2 yr of life. Pediatr Allergy Immunol 21: 5 – 13
Herberth G, Hinz D, Roder S, Schlink U, Sack U, Diez U, Borte M, Lehmann I
(2011) Maternal immune status in pregnancy is related to offspring’s
immune responses and atopy risk. Allergy 66: 1065 – 1074
Heyn H, Li N, Ferreira HJ, Moran S, Pisano DG, Gomez A, Diez J, Sanchez-Mut
JV, Setien F, Carmona FJ, Puca AA, Sayols S, Pujana MA, Serra-Musach J,
Iglesias-Platas I, Formiga F, Fernandez AF, Fraga MF, Heath SC, Valencia A
et al (2012) Distinct DNA methylomes of newborns and centenarians. Proc
Natl Acad Sci USA 109: 10522 – 10527
Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M (2002) Multiple
control of interleukin-8 gene expression. J Leukoc Biol 72: 847 – 855
Holtmann H, Winzen R, Holland P, Eickemeier S, Hoffmann E, Wallach D,
Malinin NL, Cooper JA, Resch K, Kracht M (1999) Induction of interleukin-8
synthesis integrates effects on transcription and mRNA degradation from
at least three different cytokine- or stress-activated signal transduction
pathways. Mol Cell Biol 19: 6742 – 6753
Hon GC, Rajagopal N, Shen Y, McCleary DF, Yue F, Dang MD, Ren B (2013)
Epigenetic memory at embryonic enhancers identified in DNA methylation
maps from adult mouse tissues. Nat Genet 45: 1198 – 1206
Jeffrey T, Leek W, Johnson E, Parker HS, Jaffe AE, Storey JD (2014) sva:
Surrogate Variable Analysis. R package version 3.8.0
Joetham A, Schedel M, Takeda K, Jia Y, Ashino S, Dakhama A, Lluis A, Okamoto
M, Gelfand EW (2014) JNK2 regulates the functional plasticity of naturally
occurring T regulatory cells and the enhancement of lung allergic
responses. J Immunol 193: 2238 – 2247
Joubert BR, Haberg SE, Nilsen RM, Wang X, Vollset SE, Murphy SK, Huang
Z, Hoyo C, Midttun O, Cupul-Uicab LA, Ueland PM, Wu MC, Nystad W,
Bell DA, Peddada SD, London SJ (2012) 450K epigenome-wide scan
identifies differential DNA methylation in newborns related to
maternal smoking during pregnancy. Environ Health Perspect 120:
1425 – 1431
Kasowski M, Kyriazopoulou-Panagiotopoulou S, Grubert F, Zaugg JB, Kundaje
A, Liu Y, Boyle AP, Zhang QC, Zakharia F, Spacek DV, Li J, Xie D, Olarerin-
George A, Steinmetz LM, Hogenesch JB, Kellis M, Batzoglou S, Snyder M
(2013) Extensive variation in chromatin states across humans. Science 342:
750 – 752
Kilpinen H, Waszak SM, Gschwind AR, Raghav SK, Witwicki RM, Orioli A,
Migliavacca E, Wiederkehr M, Gutierrez-Arcelus M, Panousis NI, Yurovsky
A, Lappalainen T, Romano-Palumbo L, Planchon A, Bielser D, Bryois J,
Padioleau I, Udin G, Thurnheer S, Hacker D et al (2013) Coordinated
effects of sequence variation on DNA binding, chromatin structure, and
transcription. Science 342: 744 – 747
Kulis M, Heath S, Bibikova M, Queiros AC, Navarro A, Clot G, Martinez-Trillos
A, Castellano G, Brun-Heath I, Pinyol M, Barberan-Soler S, Papasaikas P,
Jares P, Bea S, Rico D, Ecker S, Rubio M, Royo R, Ho V, Klotzle B et al
(2012) Epigenomic analysis detects widespread gene-body DNA
hypomethylation in chronic lymphocytic leukemia. Nat Genet 44:
1236 – 1242
Kupers LK, Xu X, Jankipersadsing SA, Vaez A, la Bastide-van GS, Scholtens S,
Nolte IM, Richmond RC, Relton CL, Felix JF, Duijts L, van Meurs JB,
Tiemeier H, Jaddoe VW, Wang X, Corpeleijn E, Snieder H (2015) DNA
methylation mediates the effect of maternal smoking during pregnancy
on birthweight of the offspring. Int J Epidemiol 44: 1224 – 1237
Lee KW, Richmond R, Hu P, French L, Shin J, Bourdon C, Reischl E,
Waldenberger M, Zeilinger S, Gaunt T, McArdle W, Ring S, Woodward G,
Bouchard L, Gaudet D, Smith GD, Relton C, Paus T, Pausova Z (2015)
Prenatal exposure to maternal cigarette smoking and DNA methylation:
epigenome-wide association in a discovery sample of adolescents and
replication in an independent cohort at birth through 17 years of age.
Environ Health Perspect 123: 193 – 199
Lehmann I, Thoelke A, Weiss M, Schlink U, Schulz R, Diez U, Sierig G,
Emmrich F, Jacob B, Belcredi P, Bolte G, Heinrich J, Herbarth O, Wichmann
HE, Borte M (2002) T cell reactivity in neonates from an East and a West
German city–results of the LISA study. Allergy 57: 129 – 136
Li G, Ruan X, Auerbach RK, Sandhu KS, Zheng M, Wang P, Poh HM, Goh Y,
Lim J, Zhang J, Sim HS, Peh SQ, Mulawadi FH, Ong CT, Orlov YL, Hong S,
Zhang Z, Landt S, Raha D, Euskirchen G et al (2012) Extensive promoter-
centered chromatin interactions provide a topological basis for
transcription regulation. Cell 148: 84 – 98
Liu Y, Siegmund KD, Laird PW, Berman BP (2012) Bis-SNP: combined
DNA methylation and SNP calling for Bisulfite-seq data. Genome Biol
13: R61
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods
25: 402 – 408.
Luck W, Nau H, Hansen R, Steldinger R (1985) Extent of nicotine and cotinine
transfer to the human fetus, placenta and amniotic fluid of smoking
mothers. Dev Pharmacol Ther 8: 384 – 395
Markunas CA, Xu Z, Harlid S, Wade PA, Lie RT, Taylor JA, Wilcox AJ (2014)
Identification of DNA methylation changes in newborns related to
maternal smoking during pregnancy. Environ Health Perspect 122:
1147 – 1153
Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ
(1995) Asthma and wheezing in the first six years of life. The Group
Health Medical Associates. N Engl J Med 332: 133 – 138
McVicker G, van de Geijn B, Degner JF, Cain CE, Banovich NE, Raj A,
Lewellen N, Myrthil M, Gilad Y, Pritchard JK (2013) Identification of
genetic variants that affect histone modifications in human cells. Science
342: 747 – 749
Mukamel Z, Tanay A (2013) Hypomethylation marks enhancers within
transposable elements. Nat Genet 45: 717 – 718
Murphy SK, Adigun A, Huang Z, Overcash F, Wang F, Jirtle RL, Schildkraut JM,
Murtha AP, Iversen ES, Hoyo C (2012) Gender-specific methylation
differences in relation to prenatal exposure to cigarette smoke. Gene 494:
36 – 43
Neuman A, Hohmann C, Orsini N, Pershagen G, Eller E, Kjaer HF, Gehring U,
Granell R, Henderson J, Heinrich J, Lau S, Nieuwenhuijsen M, Sunyer J,
Tischer C, Torrent M, Wahn U, Wijga AH, Wickman M, Keil T, Bergstrom A
(2012) Maternal smoking in pregnancy and asthma in preschool children:
a pooled analysis of eight birth cohorts. Am J Respir Crit Care Med 186:
1037 – 1043
O’Donnell R, Breen D, Wilson S, Djukanovic R (2006) Inflammatory cells in the
airways in COPD. Thorax 61: 448 – 454
Oken E, Levitan EB, Gillman MW (2008) Maternal smoking during pregnancy
and child overweight: systematic review and meta-analysis. Int J Obes
(Lond) 32: 201 – 210
ª 2016 The Authors Molecular Systems Biology 12: 861 | 2016
Tobias Bauer et al Epigenetic reprogramming in regulatory elements Molecular Systems Biology
17
Published online: March 24, 2016 
Painter RC, Roseboom TJ, Bleker OP (2005) Prenatal exposure to the Dutch
famine and disease in later life: an overview. Reprod Toxicol 20: 345 – 352
Quinlan AR, Hall IM (2010) BEDTools: a flexible suite of utilities for
comparing genomic features. Bioinformatics 26: 841 – 842
Raddatz G, Hagemann S, Aran D, Sohle J, Kulkarni PP, Kaderali L, Hellman A,
Winnefeld M, Lyko F (2013) Aging is associated with highly defined
epigenetic changes in the human epidermis. Epigenetics Chromatin 6: 36
Radford EJ, Ito M, Shi H, Corish JA, Yamazawa K, Isganaitis E, Seisenberger S,
Hore TA, Reik W, Erkek S, Peters AH, Patti ME, Ferguson-Smith AC (2014)
In utero effects. In utero undernourishment perturbs the adult sperm
methylome and intergenerational metabolism. Science 345: 1255903
Rechavi O, Houri-Ze’evi L, Anava S, Goh WS, Kerk SY, Hannon GJ, Hobert O
(2014) Starvation-induced transgenerational inheritance of small RNAs in
C. elegans. Cell 158: 277 – 287.
Richmond RC, Simpkin AJ, Woodward G, Gaunt TR, Lyttleton O, McArdle WL,
Ring SM, Smith AD, Timpson NJ, Tilling K, Davey Smith G, Relton CL (2015)
Prenatal exposure to maternal smoking and offspring DNA methylation
across the lifecourse: findings from the Avon Longitudinal Study of
Parents and Children (ALSPAC). Hum Mol Genet 24: 2201 – 2217
Roseboom TJ, van der Meulen JH, Ravelli AC, Osmond C, Barker DJ, Bleker OP
(2001) Effects of prenatal exposure to the Dutch famine on adult disease
in later life: an overview. Mol Cell Endocrinol 185: 93 – 98
Schwender H (2012) siggenes: Multiple testing using SAM and Efron’s
empirical Bayes approaches. R package version 1.36.0
Smyth GK (2005) Limma: linear models for microarray data. In Bioinformatics
and Computational Biology Solutions using R and Bioconductor, Gentleman R,
Carey V, Dudoit S, Irizarry R, Huber W (eds), pp 397 – 420. New York: Springer
Susser E, Neugebauer R, Hoek HW, Brown AS, Lin S, Labovitz D, Gorman JM
(1996) Schizophrenia after prenatal famine. Further evidence. Arch Gen
Psychiatry 53: 25 – 31
Takada E, Furuhata M, Nakae S, Ichijo H, Sudo K, Mizuguchi J (2013)
Requirement of apoptosis-inducing kinase 1 for the induction of bronchial
asthma following stimulation with ovalbumin. Int Arch Allergy Immunol
162: 104 – 114
Teif VB, Beshnova DA, Vainshtein Y, Marth C, Mallm JP, Hofer T, Rippe K
(2014) Nucleosome repositioning links DNA (de)methylation and
differential CTCF binding during stem cell development. Genome Res 24:
1285 – 1295
Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays
applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:
5116 – 5121
Veenendaal MV, Painter RC, de Rooij SR, Bossuyt PM, van der Post JA, Gluckman
PD, Hanson MA, Roseboom TJ (2013) Transgenerational effects of prenatal
exposure to the 1944-45 Dutch famine. BJOG 120: 548 – 553
Wang R, Ahmed J, Wang G, Hassan I, Strulovici-Barel Y, Hackett NR, Crystal
RG (2011) Down-regulation of the canonical Wnt beta-catenin pathway in
the airway epithelium of healthy smokers and smokers with COPD. PLoS
One 6: e14793
Ying Y, Tao Q (2009) Epigenetic disruption of the WNT/beta-catenin signaling
pathway in human cancers. Epigenetics 4: 307 – 312
Zang C, Schones DE, Zeng C, Cui K, Zhao K, Peng W (2009) A clustering
approach for identification of enriched domains from histone modification
ChIP-Seq data. Bioinformatics 25: 1952 – 1958
Zeilinger S, Kuhnel B, Klopp N, Baurecht H, Kleinschmidt A, Gieger C (2013)
Tobacco smoking leads to extensive genome-wide changes in DNA
methylation. PLoS One 8: e63812
Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C,
Myers RM, Brown M, Li W, Liu XS (2008) Model-based analysis of ChIP-
Seq (MACS). Genome Biol 9: R137
Zimmerman DL, Boddy CS, Schoenherr CS (2013) Oct4/Sox2 binding sites
contribute to maintaining hypomethylation of the maternal igf2/h19
imprinting control region. PLoS One 8: e81962
License: This is an open access article under the
terms of the Creative Commons Attribution 4.0
License, which permits use, distribution and reproduc-
tion in any medium, provided the original work is
properly cited.
Molecular Systems Biology 12: 861 | 2016 ª 2016 The Authors
Molecular Systems Biology Epigenetic reprogramming in regulatory elements Tobias Bauer et al
18
Published online: March 24, 2016 
